Related Experiment Videos
Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation
A D MacVicar1, J F Olliff, J Pringle
1Department of Radiology, Royal Marsden Hospital, Sutton, Surrey, England.
Radiology
|September 1, 1992
Summary
Magnetic resonance (MR) imaging after chemotherapy for Ewing sarcoma is unreliable for excluding active disease. Changes in signal intensity on MR images indicate treatment effect but do not reliably show viable tumor cells.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Ewing sarcoma is a rare bone cancer primarily affecting children and young adults.
- Accurate assessment of treatment response is crucial for patient management.
- Magnetic resonance (MR) imaging is a key modality for evaluating soft tissue tumors.
Purpose of the Study:
- To assess the signal intensity characteristics of Ewing sarcoma on MR images before and after chemotherapy.
- To determine the reliability of MR imaging in excluding active disease post-chemotherapy.
- To correlate MR imaging findings with histologic results.
Main Methods:
- Prospective study of 18 patients with biopsy-proven Ewing sarcoma.
- MR imaging performed at 1.5 T using standard spin-echo sequences (T1 and T2 weighted).
- Imaging conducted before and within 10 days after chemotherapy, with histologic correlation in 14 patients.
Main Results:
- Tumor visualized in 16/18 patients before chemotherapy.
- Post-chemotherapy MR images showed high T2-weighted signal intensity in areas of necrosis, hemorrhage, and repair.
- Viable tumor cells (microscopic) were found in both low and high signal intensity areas in 71% of patients.
Conclusions:
- MR imaging is unreliable for excluding active Ewing sarcoma after chemotherapy.
- Changes in signal intensity on MR images provide qualitative evidence of chemotherapeutic effect.
- Further research may be needed to improve MR imaging's accuracy in assessing treatment response.